Prostatic Neoplasms: all 6,484 studies
Page 31 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid TumoursCompletedNCT05518799Not applicable
- Study of 18F-Thretide PET/CT in Patients With Prostate CancerCompletedNCT05516329Phase 1/2
- Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer PatientsActive, not recruitingNCT05515978Early Phase 1
- Prostate Cancer IRE Study (PRIS)Active, not recruitingNCT05513443Not applicable
- Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate CancerStatus unknownNCT05512663Not applicable
- The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family HistoryCompletedNCT05506735
- Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated TrialActive, not recruitingNCT05500846Not applicable
- MR Fingerprinting for Diagnostic of Prostate CancerCompletedNCT05498623
- Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene AlterationsActive, not recruitingNCT05498272Phase 2
- 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR StudyActive, not recruitingNCT05496959Phase 2
- A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)TerminatedNCT05489991Phase 1/2
- Artificial Intelligence and Radiologists at Prostate Cancer Detection in MRI: The PI-CAI ChallengeCompletedNCT05489341
- Cognitive Behavioral Stress Management (CBSM) & Prostate CancerCompletedNCT05486754Not applicable
- PINPOINT Feasibility StudyStatus unknownNCT05481372Not applicable
- Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT05479578Phase 1
- ArtemiCoffee in Patients With Rising PSACompletedNCT05478239Phase 2
- Imaging and Genomic Biomarkers to Predict Response in Prostate CancerActive, not recruitingNCT05477823Early Phase 1
- Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)CompletedNCT05472532Not applicable
- Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate CancerCompletedNCT05471427
- Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate CancerActive, not recruitingNCT05471414Not applicable
- MRI Fusion Biopsy vs. Micro-Ultrasound Guided BiopsyActive, not recruitingNCT05471128
- A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYXCompletedNCT05467176
- Protein Kinase A in Prostate Cancer Tissue.Status unknownNCT05460312
- Investigation of Urinary Biomarkers for the Detection of Prostate CancerWithdrawnNCT05454371Not applicable
- Participating in Tai Chi to Reduce Anxiety and Keep up Physical FunctionActive, not recruitingNCT05452824Not applicable
- PROCLAIM: Germline Genetic Testing for Prostate Cancer PatientsCompletedNCT05447637
- N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate CancerWithdrawnNCT05445882Phase 2
- Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate CancerSuspendedNCT05445609Phase 2
- A Study of JNJ-80038114 in Participants With Advanced Stage Prostate CancerCompletedNCT05441501Phase 1
- The Performance of MRI Prostate in Men With Different Prostate Health Index (Phi) ValuesCompletedNCT05438524
- Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® SystemTerminatedNCT05437679
- Expression of STEAP-1 and p40 in Prostatic Carcinoma and Its MimickersStatus unknownNCT05428319
- The Effect of the Educatıon and Counselıng of Prostatectomy PatıentsCompletedNCT05428098Not applicable
- Comparison of Multiparametric Prostate MRI and Ga-68 PSMA PET Imaging in Prostate Cancer StagingStatus unknownNCT05427864Not applicable
- Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate CancerSuspendedNCT05425862Phase 1
- MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)Active, not recruitingNCT05424783
- Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)CompletedNCT05423431
- Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer PatientSuspendedNCT05422105
- A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate CancerActive, not recruitingNCT05416996
- Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.CompletedNCT05415787
- Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation TherapyWithdrawnNCT05415696Not applicable
- Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate CancerNo longer availableNCT05415228
- To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate CancerTerminatedNCT05405439Phase 1/2
- The Performance of da Vinci SP System on Extraperitoneal Approach Radical ProstatectomyStatus unknownNCT05403190Not applicable
- Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)Approved for marketingNCT05401214
- An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's ContinuumCompletedNCT05384002
- Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT05383079Phase 1/2
- Outcome Of Treatment Of Prostate Cancer at Sohag University Hospital Between 2017 to 2021Status unknownNCT05382182
- Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) StudyCompletedNCT05381311
- Training Data Collection & AI DevelopmentCompletedNCT05378854Not applicable
- A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate CancerStatus unknownNCT05376722Phase 2
- Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate CancerTerminatedNCT05369000Phase 1
- Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate CancerActive, not recruitingNCT05367440Phase 1/2
- MR-guided Tumour BoostActive, not recruitingNCT05364229Not applicable
- An Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apalutamide in Men With Non-metastatic Castration-resistant Prostate Cancer in Real World SettingsCompletedNCT05362149
- Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the ProstateSuspendedNCT05362032Not applicable
- Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate CancerSuspendedNCT05361915Phase 2
- A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate CancerActive, not recruitingNCT05361902Not applicable
- PROSAIC-DS Study (PROState AI in Cancer - Decision Support)Status unknownNCT05355727Not applicable
- Post Marketing Clinical Follow Up of the BioProtect Balloon Implant SystemActive, not recruitingNCT05354440
- Retrospective Evaluation of Commercial Spacers in Prostate Cancer PatientsCompletedNCT05354427
- Protons vs. Photons for High-risk Prostate CancerActive, not recruitingNCT05350475Not applicable
- Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)Active, not recruitingNCT05348577Phase 3
- Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)Active, not recruitingNCT05345444Not applicable
- Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian PopulationActive, not recruitingNCT05343936
- Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT05340374Phase 1/2
- Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)Active, not recruitingNCT05336786Phase 3
- Effectiveness Evaluation of a Self-management Program for Prostate Cancer SurvivorsCompletedNCT05335967Not applicable
- Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate CancerWithdrawnNCT05333432Not applicable
- Prostate Cancer Genius App Education and Home-based PSA Screening for African American MenActive, not recruitingNCT05331638Not applicable
- Pamiparib in mCRPC With HRD or BRCA1/2 MutationStatus unknownNCT05327621Phase 2
- Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE StudyActive, not recruitingNCT05327452Not applicable
- Evaluating the Role of Ultrasound in Prostate CancerCompletedNCT05326282Not applicable
- Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation TherapyCompletedNCT05324098Not applicable
- Prospective Evaluation of a Commercially Available Hydrogel SpacerCompletedNCT05323747
- Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D SystemActive, not recruitingNCT05322356Not applicable
- Sleep, Exercise, Nutrition and Survivorship in Prostate CancerCompletedNCT05318131Not applicable
- Evaluation of Prostate Cancer MarginsCompletedNCT05317143
- UroLift System With SAbR for Prostate Cancer and BPHCompletedNCT05311527Not applicable
- Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health SystemActive, not recruitingNCT05306600
- Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual.CompletedNCT05304169Phase 4
- A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal TherapyCompletedNCT05303558
- Social Risk Factors and Discrimination in Cancer SurvivorshipCompletedNCT05301114Not applicable
- A Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone LevelsTerminatedNCT05301062
- PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer: a Head to Head, Parallel, Prospective TrialStatus unknownNCT05297162Not applicable
- A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)TerminatedNCT05295927Phase 1
- Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss PopulationCompletedNCT05294627
- 64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate CancerStatus unknownNCT05286840Phase 1/2
- Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate CancerStatus unknownNCT05285319Phase 2
- Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.TerminatedNCT05276492Phase 1
- PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER)Active, not recruitingNCT05269550Not applicable
- Contributions of a Paramedical Approach in the Prevention and Treatment of Side Effects Associated With Radical ProstatectomyActive, not recruitingNCT05266313Not applicable
- Multiparametric Assessment of Bone Response in mCRPC Patients Treated With CabozantinibCompletedNCT05265988Phase 2
- Acute Toxicity After Moderate Hypo-fractionated Intensity Modulated Radiotherapy IMRT or Prostate CancerActive, not recruitingNCT05265364
- The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene MutationStatus unknownNCT05262608Phase 2
- Home Based Exercise for Patients With Breast or Prostate Cancer (The BENEFIT-CA Study)Status unknownNCT05258526Not applicable
- Quantitative mpMRI to Predict Metastatic Potential of Prostate CancerStatus unknownNCT05252806
- NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsTerminatedNCT05252390Phase 1
- A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT05252364Phase 1
- Clinical Validation of the Prognostic Value of the PrTS on Prostate Cancer PatientsStatus unknownNCT05248282